Source: Annual Congress 2011 - Risk assessment for tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
W. Ricketts, G. Bothamley (London, United Kingdom). The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results. Eur Respir J 2011; 38: Suppl. 55, 2663

Member's Comments

No comment yet.

Related content which might interest you: Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017 Year: 2017 Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Source: Eur Respir J 2016; 48: 1411-1419 Year: 2016 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Cut-off point for tuberculin skin test (TST) and QuantiFERON (QTF) in the diagnosis of tuberculosis infection (TI) in a study of contacts of tuberculosis (TB) Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016 Year: 2017 Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 First independent evaluation of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 47:1587-1590 Year: 2016 Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011